Amgen Stock Climbs on Rising Earnings Guidance and Dividend Strength
📈 Amgen stock closed at $385.65 on September 18, 2026, gaining 1.55% following positive news.
🚀 Management raised 2026 earnings per share guidance to a range of $22.30 to $23.50.
💰 The company pays a quarterly dividend of $2.52, annualizing to $10.08 per share.
📊 The current share price implies a dividend yield of approximately 2.6% for investors.
🛡️ Leadership signals confidence that operating performance will cover and grow the dividend.
Bullish Signals
- Amgen stock surged 1.55% to close at $385.65 on September 18, 2026, driven by rising earnings guidance.
- Management raised 2026 EPS guidance to a range of $22.30 to $23.50, demonstrating confidence in business growth.
- The company offers a strong dividend yield of approximately 2.6% with an annualized payout of $10.08 per share.
Full Analysis
Amgen's stock price surged on September 18, 2026, closing at $385.65 on Nasdaq, representing a gain of 1.55% from the previous session. This positive market reaction was driven primarily by the company's updated financial outlook and its commitment to shareholder returns through a robust dividend program.
Management has officially raised its 2026 earnings per share guidance to a range of $22.30 to $23.50. This upward revision signals strong confidence within the biotech group that its core business operations are sufficient to cover and grow its dividend payments, moving away from reliance on financial engineering tactics.
Amgen maintains an attractive dividend profile for investors, paying a quarterly dividend of $2.52 per share. When annualized, this results in a total payout of $10.08 per share, implying a yield of approximately 2.6% at the current share price, which has attracted significant attention from income-focused investors.
